6: Clinical Practice Guidelines for Head and Neck Cancers
- Page ID
- 15425
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)
- 6.2: Thyroid Cancers, Nodules, and Goitres
- 6.2.1: 1. Introduction
- 6.2.2: 2. How to Use The Guidelines
- 6.2.3: 3. Evaluating a Thyroid Nodule
- 6.2.4: 4. How to Manage a Thyroid Nodule After FNAC and/or Ultrasound
- 6.2.5: 5. Papillary Carcinoma
- 6.2.6: 6. Follicular Neoplasm
- 6.2.7: 7. Hurthle Cell Carcinoma
- 6.2.8: 8. Medullary Carcinoma
- 6.2.9: 9. Anaplastic Carcinoma
- 6.2.10: 10. Large Symptomatic Goitre
- 6.2.11: 11. Diagnostic Procedures
- 6.2.12: 12. Surgery
- 6.3: Parotid Tumors and Cancers
- 6.3.1: 1. Motivation and Methodology
- 6.3.2: 2. How to Use Guidelines
- 6.3.3: 3. Evaluation of Parotid Mass- Key Points
- 6.3.4: 4. Clinical Evaluation- History and Examination
- 6.3.5: 5. Fine Needle Aspiration Cytology (FNAC)
- 6.3.6: 6. Imaging
- 6.3.7: 7. Surgical Considerations in Under-Resourced Settings
- 6.3.8: 8. Facial Nerve in Parotidectomy
- 6.3.9: 9. Neck Dissection or Irradiation with Parotid Cancer
- 6.3.10: 10. Postoperative Radiation Therapy
- 6.3.11: 11. Parotidectomy without Radiotherapy
- 6.3.12: 12. Reccurent Pleomorphic Adenoma
- 6.4: Submandibular Salivary Gland Tumors and Cancers
- 6.4.1: 1. Motivation and Methodology
- 6.4.2: 2. How to Use Guidelines
- 6.4.3: 3. Evaluation of Submandibular Salivary Gland Mass- Key Points
- 6.4.4: 4. Clinical Evaluation- History and Examination
- 6.4.5: 5. Fine Needle Aspiration Cytology (FNAC)
- 6.4.6: 6. Imaging
- 6.4.7: 7. Surgical Considerations in Under-Resourced Settings
- 6.4.8: 8. Facial, Lingual, and Hypoglossal Nerves in Submandibular Salivary Gland Surgery
- 6.4.9: 9. Neck Dissection or Irradiation with Submandibular Salivary Gland Cancer
- 6.4.10: 10. Postoperative Radiation Therapy
- 6.4.11: 11. Histological Classification of Salivary Neoplasms
- 6.4.12: 12. TNM Classification of Submandibular Salivary Gland Cancers
- 6.5: Cancer of Glottis
- 6.5.1: 1. AfHNS Clinical Practice Guidelines for Glottic Cancers in Developing Countries and Limited Resource Settings
- 6.5.2: 2. Select Guideline According to Available to Resource Scenarios
- 6.5.3: 3. Motivation and Methodology
- 6.5.4: 4. How to Use Guidelines
- 6.5.5: 5. AfHNS Guidelines for Evaluation for Glottic Cancer- Key Points
- 6.5.6: 6. Clinical Evaluation- History and Examination
- 6.5.7: 7. Imaging
- 6.5.8: 8. TNM/AJCC Staging of Glottic Cancer
- 6.5.9: 9. Treatment Modifications in Poorly Resourced Settings
- 6.5.10: 10. Principles of Selecting Treatment
- 6.5.11: 11. Surgical Options for Glottic Cancer
- 6.5.12: 12. Indications for Neck Dissection with T3/T4 Glottic Cancers
- 6.5.13: 13. Indications for Postoperative (Chemo)Radiation Therapy
- 6.5.14: 14. Requirements for Effective Delivery for Primary Chemoradiation
- 6.5.15: 15. Anterior Commissure
- 6.6: Cancer of Supraglottis
- 6.6.1: 1. AfHNS Clinical Practice Guidelines for Supraglottic Cancers in Developing Countries and Limited Resource Settings
- 6.6.2: 2. Select Guideline According to Available Resource Scenarios
- 6.6.3: 3. Motivation and Methodology
- 6.6.4: 4. How to Use Guidelines
- 6.6.5: 5. AfHNS Guidelines for Evaluation of Supraglottic Cancer- Key Points
- 6.6.6: 6. Clinical Evaluation- History and Examination
- 6.6.7: 7. Imaging
- 6.6.8: 8. TNM/AJCC Staging of Supraglottic Cancer
- 6.6.9: 9. Treatment Modifications in Poorly Resourced Settings
- 6.6.10: 10. Principles of Selecting Treatment
- 6.6.11: 11. Surgical Options for Supraglottic Cancer
- 6.6.12: 12. Indications for Neck Dissection with Supraglottic Cancers
- 6.6.13: 13. Indications for Postoperative (Chemo)Radiation Therapy
- 6.6.14: 14. Requirements for Effective Delivery of Primary Chemoradiation
- 6.7: Cancer of Hypopharynx
- 6.7.1: 1. AfHNS Clinical Practice Guidelines for Hypopharyngeal Cancers in Developing Countries and Limited Resource Settings
- 6.7.2: 2. Select Guideline According to Available Resource Scenarios
- 6.7.3: 3. Motivation and Methodology
- 6.7.4: 4. How to Use Guidelines
- 6.7.5: 5. AfHNS Guidelines for Evaluation of Hypopharyngeal Cancer- Key Points
- 6.7.6: 6. Clinical Evaluation - History and Examination
- 6.7.7: 7. Imaging
- 6.7.8: 8. TNM/AJCC Staging of Hypopharyngeal Cancer
- 6.7.9: 9. Treatment Modifications in Poorly Resourced Settings
- 6.7.10: 10. Principles of Selecting Treatment
- 6.7.11: 11. Surgical Options for Hypopharyngeal Cancers
- 6.7.12: 12. Indications for Neck Dissection with Hypopharyngeal Cancers
- 6.7.13: 13. Indications for Postoperative (Chemo)Radiation Therapy
- 6.7.14: 14. Requirements for Effective Delivery of Primary Chemoradiation
- 6.8: Cancer of Oral Cavity
- 6.8.1: 1. AfHNS Clinical Practice Guidelines for Oral Cancers in Developing Countries and Limited Resource Settings
- 6.8.2: 2. Select Guideline According to Available Resource Scenarios
- 6.8.3: 3. Motivation and Methodology
- 6.8.4: 4. How to Use Guidelines
- 6.8.5: 5. AfHNS Guidelines for Evaluation of Oral Cancer- Key Points
- 6.8.6: 6. Clinical Evaluation- History and Examination
- 6.8.7: 7. Imaging
- 6.8.8: 8. TNM/AJCC Staging of Oral Cancer
- 6.8.9: 9. Oral Cancer - Depth of Invasion
- 6.8.10: 10. Treatment Modifications in Poorly Resourced Settings
- 6.8.11: 11. Indications for Neck Dissection with Oral Cancer
- 6.8.12: 12. Indications for Postoperative (Chemo)Radiation Therapy
- 6.9: Cancer of Oropharynx
- 6.9.1: 1. AfHNS Clinical Practice Guidelines for Oropharyngeal Cancers in Developing Countries and Limited Resource Settings
- 6.9.2: 2. Select Guideline According to Available Resource Scenarios
- 6.9.3: 3. Motivation and Methodology
- 6.9.4: 4. How to Use the Guidelines
- 6.9.5: 5. Evaluation of Oropharyngeal Cancer- Key points
- 6.9.6: 6. HPV-Related Oropharyngeal Cancer
- 6.9.7: 7. Staging Oropharyngeal Cancers- P16-
- 6.9.8: 8. Staging Oropharyngeal Cancers- P16+
- 6.9.9: 9. Clinical Evaluation- History and Examination
- 6.9.10: 10. Imaging
- 6.9.11: 11. Optimal Therapeutic Approach Not Easily Defined
- 6.9.12: 12. Indications for Neck Dissection or Irradiation
- 6.9.13: 13. Indications for Postoperative (chemo)radiation Therapy
- 6.9.14: 14. Administration of Chemoradiation Therapy
- 6.9.15: 15. Treatment Modifications in Poorly Resourced Settings
- 6.9.16: 16. Surgical Approaches - Oropharynx Cancer Resection- Transoral Lateral Oropharyngectomy (Radical Tonsillectomy)
- 6.9.17: 17. Surgical Approaches - Oropharynx Cancer Resection- External Approaches
- 6.9.18: 18. Oropharynx Cancer Resection- Base of Tongue
- 6.9.19: 19. Transoral CO2 Laser Microsurgery (TLM)